The United States Patent and Trademark Office (USPTO) has received an intent-to-use trademark application (TM99716950) for the mark WELLSY. The application, filed on March 22, 2026, seeks to cover a broad range of telemedicine and remote medical services. These include clinical evaluation, diagnosis, treatment, and medication management for primary care, urgent care, dermatology, chronic condition management, women's and men's health, and preventive counseling, as well as interactive medical monitoring and alert services for medication adherence.

This filing indicates a planned expansion into the telemedicine and remote healthcare services market. While this is a trademark application and not a regulatory rule, it signals potential future service offerings that may be subject to healthcare regulations. Compliance officers should note the scope of services described, particularly those related to diagnosis, treatment, and medication management, as these fall under stringent regulatory oversight by bodies like the FDA and CMS.